Capvizr
THE DEAL, AT A GLANCE

Noom

From the announcement
01What it doesThe new capital is framed around Launch Noom Med GLP-1 clinical program and expand globally.From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
02Who is involvedBacked by Silver Lake, VariousFrom the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
03What happenedNoom raised $540M Series FFrom the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
04Why it mattersNoom’s Series F supports a shift from psychology-based weight-loss coaching toward a broader AI-powered weight and health platform anchored by Noom Med and global…From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗

Noom · Financing Record

Explore source-linked visual explanations for Noom. Unsupported claims are withheld while source review continues.

Record 325 · Recorded date: Needs review

What it does

Noom: illustrative category image
Illustrative image (biotech lab), not Noom's product · Stephane Lesbats (IFREMER, Pôle Images, Centre Bretagne - ZI / CC BY 4.0

Unsupported business claims are withheld pending source review. Explore the linked records for available evidence.

Open record 325 →

Explore company records →
Free weekday briefing

Know which funding rounds matter before the first call.

Source-linked rounds, lead investors, and the signal behind the capital. One five-minute read.

Free · Unsubscribe anytime